Pendant sa présentation en plénière au congrès de l’ASCO 2017, le Pr Karim Fizazi de Gustave Roussy rend hommage aux patients qui ont participé à l’étude LATITUDE.
A 38% reduction in the risk of death in treatment of patients with metastatic prostate cancer
The findings of a large clinical study are going to change the preferred methods of treatment of metastatic prostate cancer which have remained almost unchanged for 70 years.